Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Myeloperoxidase Aids Heart Attack Risk Prediction With Chest Pain – Study

This article was originally published in The Gray Sheet

Executive Summary

Blood tests for glutathione peroxidase 1 and myeloperoxidase could be used to identify patients at high-risk for adverse coronary events, according to Teri Manolio, MD/PhD, National Heart, Lung & Blood Institute

You may also be interested in...



AACC Speakers Seek Cost-Efficient Cardiac Biomarker Panel

Healthcare cost pressures appear to be shifting the burden of stratifying potential acute coronary syndrome patients to earlier in the hospitalization process

AACC Speakers Seek Cost-Efficient Cardiac Biomarker Panel

Healthcare cost pressures appear to be shifting the burden of stratifying potential acute coronary syndrome patients to earlier in the hospitalization process

Vulnerable Plaque Diagnosis, Treatment: Is Enrollment “Impossible”?

Diagnostic modalities and therapies for vulnerable plaque should be tested simultaneously in one clinical trial to ensure the enrollment size is manageable, according to cardiac researcher James Muller, MD, Massachusetts General Hospital

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel